share_log

Chengdu Bright Eye Hospital Co., Ltd.'s (SZSE:301239) Market Cap Increased by CN¥372m, Insiders Receive a 44% Cut

Chengdu Bright Eye Hospital Co., Ltd.'s (SZSE:301239) Market Cap Increased by CN¥372m, Insiders Receive a 44% Cut

成都明目醫院股份有限公司(深證股份編號:301239)市值增加37200萬元人民幣,內部人員接受了44%的削減。
Simply Wall St ·  07/17 19:57

Key Insights

主要見解

  • Insiders appear to have a vested interest in Chengdu Bright Eye Hospital's growth, as seen by their sizeable ownership
  • The top 3 shareholders own 50% of the company
  • Institutions own 29% of Chengdu Bright Eye Hospital
  • 內部人士似乎對成都明目眼科醫院的增長有着固執的利益,這可以從他們的龐大所有權中看出。
  • 前 3 名股東擁有公司的 50%。
  • 機構擁有成都明目眼科醫院的29%股份。

Every investor in Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239) should be aware of the most powerful shareholder groups. With 44% stake, individual insiders possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

成都明目眼科醫院有限公司(SZSE:301239)的每位投資者都應該知道最強大的股東群體。由於個人內部人士持有44%的股份,所以這個群體在公司中持有最多的股份。也就是說,如果股票上漲,他們將獲得最大的利益(或者如果出現衰退,則承受最大的損失)。

As a result, insiders were the biggest beneficiaries of last week's 7.5% gain.

因此,內部人士是上週7.5%漲幅的最大受益者。

Let's take a closer look to see what the different types of shareholders can tell us about Chengdu Bright Eye Hospital.

讓我們仔細觀察一下不同類型的股東對成都明目眼科醫院的影響。

big
SZSE:301239 Ownership Breakdown July 17th 2024
SZSE:301239所有權分佈圖(2024年7月17日)

What Does The Institutional Ownership Tell Us About Chengdu Bright Eye Hospital?

機構所有權對成都明目眼科醫院有什麼意義?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

Chengdu Bright Eye Hospital already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Chengdu Bright Eye Hospital, (below). Of course, keep in mind that there are other factors to consider, too.

成都明目眼科醫院的股份登記簿上已經有了機構。的確,他們在公司中擁有可觀的股份。這表明公司在投資界有一定的信譽。然而,最好謹慎地依賴機構投資者所謂的認可。他們也會有錯誤。如果兩個大型機構投資者同時試圖賣出股票,往往會看到股價大幅下跌。因此,值得檢查成都明目眼科醫院的過去收益軌跡(如下所示)。當然,也要記住還有其他因素需要考慮。

big
SZSE:301239 Earnings and Revenue Growth July 17th 2024
SZSE:301239收入和營收增長(2024年7月17日)

Chengdu Bright Eye Hospital is not owned by hedge funds. The company's largest shareholder is Xuyang Xu, with ownership of 43%. Fusui Zhengxin Investment Partnership Enterprise (Limited Partnership) is the second largest shareholder owning 4.0% of common stock, and Fusui Jinguan Qingcheng Investment Partnership Enterprise (Limited Partnership) holds about 3.1% of the company stock.

成都明目眼科醫院沒有被對沖基金所擁有。該公司最大的股東是許旭陽,持有43%的所有權,而福建知行投資合夥企業(有限合夥)持有普通股的4.0%,福建福瑞景冠清誠投資合夥企業(有限合夥)則擁有公司股份的約3.1%。

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

總的來說,包括散戶投資者在內,公衆擁有公司的14%的股份,因此不能輕易忽視。儘管這種所有權的規模可能不足以在他們的利益方面影響政策決策,但他們仍然可以對公司政策產生集體影響。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.

儘管有必要研究公司的機構持股數據,但研究分析師的情緒也是有道理的,以了解風向。這隻股票有一些分析師的覆蓋,但不多。因此,有提高更多的分析涵蓋面的空間。

Insider Ownership Of Chengdu Bright Eye Hospital

成都明目眼科醫院的內部人士所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

內部人員的定義在不同國家之間可能略有不同,但董事會成員始終計數。公司管理層回答董事會,在此應代表股東利益。值得注意的是,有時高級管理人員也在董事會上。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。

Our information suggests that insiders maintain a significant holding in Chengdu Bright Eye Hospital Co., Ltd.. Insiders own CN¥2.4b worth of shares in the CN¥5.4b company. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

我們的信息顯示,內部人士在成都明目眼科醫院股份有重要持股。內部人士在該54億元公司中擁有24億元的股份。這可能意味着創始人仍然擁有大量股份。你可以點擊這裏查看他們是否一直在買賣。

General Public Ownership

一般大衆所有權

With a 18% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Chengdu Bright Eye Hospital. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

普通公衆擁有18%的所有權,這主要由個人投資者組成,他們對成都明目眼科醫院有一定的影響力。雖然這種所有權的規模可能不足以在政策決策方面發揮影響力,卻仍然能夠對公司政策產生集體影響。

Private Company Ownership

私有公司的所有權

Our data indicates that Private Companies hold 8.9%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我們的數據表明,私人公司持有該公司8.9%的股份。僅從這個事實本身很難得出任何結論,因此值得進一步了解持有這些私人公司的人。有時,內部人或其他相關方可能通過單獨的私人公司持有一家上市公司的股份。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 2 warning signs for Chengdu Bright Eye Hospital that you should be aware of before investing here.

《考慮擁有一家公司的不同群體》雖然考慮擁有公司的不同群體是值得的,但是還有更重要的因素。例如,我們發現了成都明目眼科醫院的兩個警示信號,您在在這裏投資之前,應該注意它們。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果您想發現分析師對未來增長的預測,請不要錯過這份有關分析師預測的免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容感到擔憂?請直接與我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?對內容感到擔憂?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論